Trial Profile
TAILoR - (TelmisArtan and InsuLin Resistance in HIV): A dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy (cART)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Aug 2019
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary) ; Antiretrovirals
- Indications Insulin resistance
- Focus Therapeutic Use
- Acronyms TAILoR
- 03 Jul 2019 Results published in the Clinical Infectious Diseases.
- 07 Jun 2019 Status changed from active, no longer recruiting to completed.
- 10 Sep 2015 Planned End Date changed from 30 Nov 2016 to 30 Jul 2015 as reported by United Kingdom Clinical Research Network.